Oral Administration of EP4-selective Agonist KAG-308 Suppresses Mouse Knee Osteoarthritis Development Through Reduction of Chondrocyte Hypertrophy and TNF Secretion
Scientific Reports - United Kingdom
doi 10.1038/s41598-019-56861-6
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 2019
Authors
Publisher
Springer Science and Business Media LLC